Literature DB >> 9616493

Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide.

J Matte1, F Roufosse, P Rocmans, A Schoutens, D Jacobovitz, J Mockel.   

Abstract

The differential diagnosis and management of Cushing's syndrome remain difficult, particularly for ectopic adrenocorticotropin (ACTH) syndromes resulting from small bronchial carcinoids. We report the case of a 41-year-old man with ectopic ACTH-dependent Cushing's syndrome. Two computed tomography scans of the thorax were normal and magnetic resonance imaging of the chest showed a 6-mm hyperintense T1-weighted area close to the left pulmonary hilus, interpreted as probably vascular by the radiologists. An [111In-DTPA-D-Phe1]octreotide scintigraphy scan demonstrated a positive image for somatostatin receptors in exactly the same location and surgery confirmed the presence of a small ACTH-secreting carcinoid tumour in the upper left lung lobe which was resected. Surgery cured the hypercorticism of the patient. The differential diagnosis of Cushing's syndrome and the procedure for localisation of an ACTH source are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616493      PMCID: PMC2360809          DOI: 10.1136/pgmj.74.868.108

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.

Authors:  L K Nieman; G P Chrousos; E H Oldfield; P C Avgerinos; G B Cutler; D L Loriaux
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

2.  Somatostatin receptor scintigraphy and the ectopic ACTH syndrome--the solution or just another test?

Authors:  J L Doppman
Journal:  Am J Med       Date:  1994-04       Impact factor: 4.965

3.  Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.

Authors:  W W de Herder; E P Krenning; C D Malchoff; L J Hofland; J C Reubi; D J Kwekkeboom; H Y Oei; H A Pols; H A Bruining; F R Nobels
Journal:  Am J Med       Date:  1994-04       Impact factor: 4.965

Review 4.  Management of the ectopic ACTH syndrome due to thoracic carcinoids.

Authors:  H I Pass; J L Doppman; L Nieman; M Stovroff; J Vetto; J A Norton; W Travis; G P Chrousos; E H Oldfield; G B Cutler
Journal:  Ann Thorac Surg       Date:  1990-07       Impact factor: 4.330

5.  Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT.

Authors:  J L Doppman; H I Pass; L K Nieman; J W Findling; A J Dwyer; I M Feuerstein; A Ling; W D Travis; G B Cutler; G P Chrousos
Journal:  AJR Am J Roentgenol       Date:  1991-01       Impact factor: 3.959

6.  Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome.

Authors:  N J Woodhouse; S Dagogo-Jack; M Ahmed; R Judzewitsch
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

7.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

8.  The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.

Authors:  P C Avgerinos; J A Yanovski; E H Oldfield; L K Nieman; G B Cutler
Journal:  Ann Intern Med       Date:  1994-09-01       Impact factor: 25.391

Review 9.  Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.

Authors:  N W Cheung; S C Boyages
Journal:  Clin Endocrinol (Oxf)       Date:  1992-04       Impact factor: 3.478

10.  The Cushing syndrome induced by bronchial carcinoid tumors.

Authors:  A H Limper; P C Carpenter; B Scheithauer; B A Staats
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

  10 in total
  5 in total

1.  Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?

Authors:  G I Uwaifo; C A Koch; B Hirshberg; C C Chen; P Hartzband; L K Nieman; K Pacak
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

Review 2.  Somatostatin receptor imaging for neuroendocrine tumors.

Authors:  Wouter W de Herder; Dik J Kwekkeboom; Richard A Feelders; Maarten O van Aken; Steven W J Lamberts; Aart-Jan van der Lely; Eric P Krenning
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report.

Authors:  Armaghan Fard Esfahani; Maryam Chavoshi; Mohammad Hadi Noorani; Mohsen Saghari; Mohammad Eftekhari; Davood Beiki; Babak Fallahi; Majid Assadi
Journal:  J Med Case Rep       Date:  2010-10-18

4.  ACTH-Producing Cholangiocarcinoma Associated with Cushing's Syndrome.

Authors:  George Papastratis; George N. Zografos; Harris C. Pappis; George Kontogeorgos; George Anagnostopoulos; Theodora Kounadi; George Piaditis
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

5.  The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors.

Authors:  Zeynep Gözde Özkan; Serkan Kuyumcu; Deniz Balköse; Berker Ozkan; Nihat Aksakal; Ebru Yılmaz; Yasemin Sanlı; Cüneyt Türkmen; Ferihan Aral; Işik Adalet
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.